BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mendel Trait Technology Advances Towards Commercial Launch


9/28/2011 10:27:23 AM

HAYWARD, Calif., Sept. 28, 2011 /PRNewswire/ -- Mendel Biotechnology Inc. ("Mendel") announced today that a regulatory petition by Monsanto Company was made recently to the USDA for soybean plants containing Mendel's leading yield gene. The filing is a key part of the regulatory path as the trait moves closer to commercial launch. Approval of the petition is one of the final milestones needed to make the high yield soybean plants available to farmers.

The underlying yield gene represents Mendel's flagship commercial trait technology and was discovered and developed through a research collaboration funded by Monsanto leveraging Mendel's deep expertise in plant gene regulation and network biology. Mendel possesses patent rights related to this yield gene in major agricultural production geographies and sees application potential for the gene to be licensed in various fields, including forestry, energy crops and others. Mendel, which has remained privately held since it was founded in 1997, has developed a leading portfolio of ag biotech traits for improved yield and stress tolerance in large acreage and high value crops. In addition to already having a number of trait technologies that were developed in the past decade, Mendel is deploying a suite of state-of-the-art, genomics-based technical platforms for discovery and development of new technologies to meet global yield and stress tolerance targets and the need for improved efficiency of using resources like water and nitrogen.

As well as working to commercialize its current traits, Mendel is also deploying its knowledge of plant gene regulatory networks to the discovery of novel chemistries to improve plant performance in its Chemistry business segment, and to the development of improved varieties of the premier energy crop, miscanthus, in its Seeds business segment.

"We are absolutely delighted that Monsanto has submitted a dossier for deregulation of soybean plants that contain our high-yield gene. This submission underscores our belief in the potential of our technology strategy and business and validates our long term R&D strategy focused on understanding and improving the regulation of gene networks that control important plant traits," said Neal Gutterson, President and Chief Executive Officer of Mendel. "With the continued development of this and other technologies, we are now in position to apply our knowledge of gene networks and our technology platforms to the discovery and development of additional biotech traits."

About Mendel

Mendel is a premier independent corporation serving large agricultural companies with new genetic and chemical solutions for improvement of crop yield and resource use efficiency and is also dedicated to becoming the leading seed company serving the bioenergy industry. Mendel's technology organization has a very deep expertise base in the application of functional genomics to the study of plant genes and the company is also a pioneer in the production of dedicated energy crops critical for second generation biofuels. Mendel has identified and patented the use of genes that control many aspects of plant growth and development, and is applying these inventions to develop or co-develop new plant varieties with improved productivity and quality. Mendel has relationships with leading agricultural, energy, forestry and horticulture companies for the commercialization of improved seed and plant products, and is developing new seed and feedstock products for the emerging bioenergy markets. For more information, visit: www.mendelbio.com.

Contact: Oliver J. Ratcliffe, Sr. Vice President, Research. Ph.: (510) 259-6146

SOURCE Mendel Biotechnology Inc.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES